openPR Logo

Press Releases from Roots Analysis (199 total)

The gene therapy market is projected to be worth USD 17.3 billion in 2035, growi …

Given the potential of gene therapies to permanently cure a diverse array of clinical conditions at the genetic level, the current pipeline is rapidly growing; a number of such therapies are currently being evaluated in late stages of development London Roots Analysis has announced the addition of "Gene Therapy Market" report to its list of offerings. Post the emergence of blockbuster gene therapies, such as ZOLGENSMA® (for spinal muscular atrophy type

The companion diagnostics development services market, is anticipated to grow at …

Roots Analysis has announced the addition of "Companion Diagnostics Development Services Market (2nd Edition), 2022-2035" report to its list of offerings. The growing pipeline of patient-centric targeted therapies has led to a surge in demand for companion diagnostics; these tests are known to improve the success rates of late-stage trials by almost three-fold. The development and approval of these FDA classified high-risk devices requires multidisciplinary expertise and an established network of

The viral vaccine cell culture media market is projected to grow at a CAGR of 5. …

Roots Analysis has announced the addition of the "Viral Vaccine Cell Culture Media Market, 2022-2035" report to its list of offerings. Vaccine production is a highly regulated and challenging process; specifically, the production of viral components or whole viruses further adds to the complexity. Additionally, it is paramount for vaccine cultures to be devoid of any contamination and be highly effective. In order to mitigate the aforementioned challenges, pharma and

The continuous manufacturing market is projected to grow at an annualized rate o …

Roots Analysis has announced the addition of "Continuous Manufacturing Market - Small Molecules and Biologics (2nd Edition), 2022-2035" (https://www.rootsanalysis.com/reports/view_document/continuous-manufacturing/308.html) report to its list of offerings. The outbreak COVID-19 pandemic had disruptive impact on the overall pharmaceutical supply chain, due to the absence of workers at manufacturing sites and distribution networks' restrictions. Continuous manufacturing offers a practicable solution as the continuous processes are automated on a larger scale, and the FDA and

The oral proteins and peptides market is anticipated to grow at a CAGR of 20%, d …

Roots Analysis has announced the addition of "Oral Proteins and Peptides Market, 2022-2032" report to its list of offerings. Over the past few years, technological advancements in delivery formulations have enabled the adoption of the oral route of administration in lieu of the widely adopted subcutaneous route. Since the approval of the first oral protein / peptide in 2012, there has been an increase in the demand for this class of

The clinical trials software market is projected to be growing at a CAGR of 14%, …

Roots Analysis has announced the addition of "Clinical Trials Software Market, 2022-2035" report to its list of offerings. Excessive capital expenditure and other complexities associated with the traditional clinical trials has imposed an enormous financial burden on the pharmaceutical industry. Virtual clinical trials software solutions have the potential to induce substantial digital changes in clinical research methodology, resulting in a more patient-centric, cost-effective and easy to manage approach. To order this 270+

Novel Drug Reconstitution Systems Market, 2021-2030

In 2018, seven out of ten top-selling prescription medicines were biologics. The liquid formulations of biologics are not much stable and tend to lose efficacy with time due to the changes in their pharmacokinetic and pharmacodynamic properties. Therefore, lyophilization of such drugs is essential before their storage. Around 50% of the biologics intended for parenteral administration are available in lyophilized form, which require reconstitution before administration. To Request for sample -

Squamous Non-small Cell Lung Cancer Market, 2021-2031 by Roots Analysis

Advances in molecular biology and tumor immunology have enabled the development of NSCLC targeting therapies, which have the ability to impede cancer growth by altering chemical reactions associated with oncogenic driver mutations Roots Analysis has announced the addition of “Squamous Non-small Cell Lung Cancer Market, 2021-2031” report to its list of offerings. Success of approved squamous non-small cell lung cancer therapies, such as Keytruda®, Opdivo® and Portrazza®, has resulted in a

The TIL-based therapies market is projected to be worth over USD 4.3 billion, by …

Driven by the potential to confer sustained therapeutic effects and thereby, facilitate prolonged periods of remission, TIL-based therapies have received significant financial support, and promising leads are poised to soon achieve blockbuster status Roots Analysis has announced the addition of “TIL-based Therapies Market, 2021-2030” report to its list of offerings. Given the frequently reported inadequacies of conventional cancer therapies and the growing need for personalized medicine, there is a marked surge

The novel ocular drug delivery devices market is projected to grow at a CAGR of …

The delivery of drugs in ocular regions is known to be considerably more challenging; several pharmaceutical companies are actively undertaking initiatives to identify novel approaches for safe and efficient administration of therapies to eyes Roots Analysis has announced the addition of the “Novel Ocular Drug Delivery Devices Market, 2021 – 2030” report to its list of offerings. Over the years, a number of companies have developed several novel and advanced drug

The progressive supranuclear palsy (PSP) therapies market, is anticipated to gro …

The exact cause of this rare disorder, which affects 5-17 in 100,000 people, is unknown; however, a complex interplay between different risk factors, including age, genetics and environment, is likely to contribute to the onset of this rare tauopathy London Roots Analysis has announced the addition of “Progressive Supranuclear Palsy Therapies Market, 2021-2030” report to its list of offerings. Presently, there is no cure for PSP and the effectiveness of prescribed generic

The soft tissue sarcoma market is projected to be worth over USD 420 million in …

Recent advances in molecular biology have enabled researchers to develop a better understanding of the rare soft tissue sarcomas; as a result, a number of viable biological targets have been identified and are being investigated for therapeutic relevance Roots Analysis has announced the addition of “Soft Tissue Sarcoma: Focus on Angiosarcoma, Chondrosarcoma, and Liposarcoma Market, 2021-2030” report to its list of offerings. Soft tissue sarcoma is a rare form of cancer

The squamous non-small cell lung cancer market is projected to grow at a CAGR of …

Over time, important advances in diagnosis and the development of versatile treatment options have translated into tangible improvements in the overall survival of lung cancer patients; several targeted therapies are being developed against squamous NSCLCs Roots Analysis is pleased to announce the publication of its recent study, titled, “Squamous Non-small Cell Lung Cancer Market, 2021-2031.” For more information please click on the following link: https://www.rootsanalysis.com/reports/squamous-non-small-cell-lung-cancer-market.html The report features an in-depth analysis of the

Porphyria Targeting Therapies Market, 2021-2030

Roots Analysis has announced the addition of “Porphyria Targeting Therapies Market, 2021-2030” report to its list of offerings. Porphyria is a rare disorder that is characterized by excessive accumulation of porphyrin, a compound that aids in the formation of heme (an essential part of hemoglobin that helps carry oxygen in blood). Any anomaly caused by genetic or acquired abnormalities in heme biosynthesis (produced majorly in bone marrow and liver) can

Display Library Technologies and Affiliated Services Market by Roots Analysis

Given the various limitations of the conventional drug discovery methods, the innovator companies are increasingly adopting the advanced technologies, such as display-library technologies for rapid and successful screening of novel therapeutics London Roots Analysis has announced the addition of “Display Library Technologies and Affiliated Services Market, 2021-2030” report to its list of offerings. Display libraries have been successfully employed for the generation of various novel therapeutics and offer certain advantages over conventional drug

Elastomeric Closure Components Market by Roots Analysis

To order this detailed 400+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/elastomeric-closures-market-focus-on-parenteral-containers-2019-2030/255.html Key Inclusions  A detailed assessment of the current market landscape of companies manufacturing elastomeric container closures, featuring information on the type of closure (cap, needle shield, plunger, seal, stopper, and tip cap), type of respective primary container(s) (vial, syringe, and cartridge), elastomeric material(s) used for fabricating the aforementioned closures (such as bromobutyl, chlorobutyl, and others), drug type(s) that are compatible

The global collaborative robots (cobots) market is projected to be worth USD 18 …

Roots Analysis is pleased to announce the publication of its recent study, titled, “Global Collaborative Robots (Cobots) Market, 2020-2030.” The report features an extensive study of the potential applications, current landscape and the likely adoption of cobots across various industrial applications, over the next decade. The study features an in-depth analysis, highlighting the capabilities of various industry stakeholders engaged in this field. In addition to other elements, the study includes:  An overview

Global Psychedelic therapeutics market is estimated to be worth over USD 6.5 bil …

A growing body of evidence suggests that using psychedelics, such as psilocybin and LSD, in combination with psychotherapy, can treat the symptoms of several mental health conditions, including depression and substance use disorders Roots Analysis has announced the addition of “Global Psychedelic Therapeutics Market, 2020-2030” report to its list of offerings. The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of

The microbial contract biomanufacturing market is estimated to be worth USD 9.3 …

Benefits offered by microbial biomanufacturing, such as low production costs and faster development timelines, have led many innovators to adopt these platforms for next generation biologics, offering lucrative opportunities for CMOs / CDMOs Roots Analysis is pleased to announce the publication of its recent study, titled, “Microbial Contract Biomanufacturing Market, 2020-2030. The report features an extensive study of the current market landscape and future opportunities associated with the microbial contract biomanufacturing market.

The porphyria therapies market is projected to grow at an annualized rate of 10. …

Several novel and innovative therapeutic approaches, both small molecule and biologics, are being currently investigated at various phases of development in order to avoid the beginning of disease-induced attacks and other long-term effects of porphyria Roots Analysis has announced the addition of “Porphyria Targeting Therapies Market, 2021-2030” report to its list of offerings. Porphyria is a rare disorder that is characterized by excessive accumulation of porphyrin, a compound that aids in

Elastomeric Closure Components Market by Roots Analysis

To order this detailed 400+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/elastomeric-closures-market-focus-on-parenteral-containers-2019-2030/255.html Key Inclusions  A detailed assessment of the current market landscape of companies manufacturing elastomeric container closures, featuring information on the type of closure (cap, needle shield, plunger, seal, stopper, and tip cap), type of respective primary container(s) (vial, syringe, and cartridge), elastomeric material(s) used for fabricating the aforementioned closures (such as bromobutyl, chlorobutyl, and others), drug type(s) that are compatible

The viral and non-viral vector manufacturing market is projected to grow at an a …

The rapidly growing pipeline of genetically modified therapies reflects the surge in demand for high quality vectors, presenting lucrative opportunities for companies with the capabilities to manufacture viral and non-viral gene delivery solutions London Roots Analysis has announced the addition of “Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market (4th Edition) 2021 – 2030” report to its list of offerings. Over time, ~15 cell and gene therapies have been approved across the

Targeted Protein Degradation Market, 2021-2030

Targeted protein degradation has emerged as a revolutionary pharmacological concept that presents both viable and versatile drug development opportunities and is anticipated to introduce a new paradigm in modern healthcare London Roots Analysis has announced the addition of “Targeted Protein Degradation Market, 2021-2030” report to its list of offerings. Small-molecule-induced protein degradation has been demonstrated to possess the potential to drug a broader range of proteinaceous biological targets. It involves the

Real World Evidence Market, (2nd Edition) - Roots Analysis

In modern healthcare, the applications of real world data-based insights are vast, ranging from drug discovery to supporting regulatory decision-making; in fact, the US FDA routinely uses real world evidence to monitor post market safety of drugs Roots Analysis has announced the addition of “Pharmaceutical and Life Sciences Real World Evidence Market, (2nd Edition), 2021-2030” report to its list of offerings. The digitization of data and advances in information processing, have

RAS Targeting Therapies Market, 2021-2031 by Roots

Roots Analysis has announced the addition of “RAS Targeting Therapies Market, 2021-2031” report to its list of offerings. To order this 140+ page report, which features 95+ figures, please visit https://www.rootsanalysis.com/reports/ras-targeting-therapies-market.html Key Inclusions  A detailed overview of the current market landscape of RAS targeting therapies, along with information on several relevant parameters, such as current status of development (marketed, clinical, pre-clinical and discovery), phase of development (phase III, phase II, phase I /

The porphyria therapies market is projected to grow at an annualized rate of 10. …

Several novel and innovative therapeutic approaches, both small molecule and biologics, are being currently investigated at various phases of development in order to avoid the beginning of disease-induced attacks and other long-term effects of porphyria Roots Analysis has announced the addition of “Porphyria Targeting Therapies Market, 2021-2030” report to its list of offerings. Porphyria is a rare disorder that is characterized by excessive accumulation of porphyrin, a compound that aids in

The outsourced cell therapy consumables market is likely to grow at a significan …

In order to keep pace with ongoing advances related to materials and regulatory scenarios, and to facilitate the cell therapy manufacturing process, cell therapy consumable providers are steadily evolving Roots Analysis is pleased to announce the publication of its recent study, titled, “Cell Therapy Consumables Market, 2021 – 2031”. For additional details, please visit https://www.rootsanalysis.com/reports/cell-therapy-consumables-market.html or email sales@rootsanalysis.com The report features an extensive study on the consumable providers within the cell therapy

The squamous non-small cell lung cancer market is projected to grow at a CAGR of …

Over time, important advances in diagnosis and the development of versatile treatment options have translated into tangible improvements in the overall survival of lung cancer patients; several targeted therapies are being developed against squamous NSCLCs Roots Analysis is pleased to announce the publication of its recent study, titled, “Squamous Non-small Cell Lung Cancer Market, 2021-2031.” The report features an in-depth analysis of the product pipeline and developer companies, highlighting the current treatment

The teleradiology services market is projected to grow at a CAGR of 16.8% till 2 …

Roots Analysis has announced the addition of “Teleradiology Services Market, 2021-2030” market report to its list of offerings. The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these services over the next decade. The report features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. Amongst other elements, the report includes:  A detailed assessment of the current

The Alzheimer’s disease market is anticipated to grow at an annualized rate of …

The recent approval of Aduhelm™, an amyloid beta-directed antibody has led to players seeking approval for similar therapies; various interventions are being evaluated for the treatment / management of the inherently complex neurodegenerative disease Roots Analysis has announced the addition of “Alzheimer's Disease Market (2nd Edition), 2021-2031” report to its list of offerings. Limited treatment options and unmet needs are the key drivers of research activity in this domain. Several industry and

The glycosylation analysis services market is projected to reach nearly USD 2.5 …

The rapidly growing pipeline of recombinant glycoprotein therapeutics, especially the glycoengineered variants of COVID-19 drugs, has presented lucrative opportunities for contract service providers with expertise in glycoconjugate / glycan analysis Roots Analysis is pleased to announce the publication of its recent study, titled, “Glycosylation Analysis Services Market, 2021 – 2030” For more information, please click on the following link: https://www.rootsanalysis.com/reports/glycosylation-analysis-services-market.html The report features an extensive study on the current market landscape, offering an

The progressive supranuclear palsy (PSP) therapies market, is projected to grow …

The exact cause of this rare disorder, which affects 5-17 in 100,000 people, is unknown; however, a complex interplay between different risk factors, including age, genetics and environment, is likely to contribute to the onset of this rare tauopathy Roots Analysis is pleased to announce the publication of its recent study, titled, “Progressive Supranuclear Palsy Therapies Market, 2021-2030” The report features an extensive study of the current market landscape, offering an informed

The light activated therapies market is anticipated to grow at an annualized rat …

Light activated therapies are considered to be a transformative approach owing to their capability to eradicate diseased cells from the body with minimal side effects; presenting lucrative opportunities for players engaged in the development of such products London Roots Analysis has announced the addition of “Light Activated Therapies Market: Focus on Photodynamic Therapies, Photoimmunotherapies and Photothermal, 2021-2030“ report to its list of offerings. Rising prevalence of skin disorders is expected to

Pharmaceutical Contract Research Services Market, 2021-2030 by Roots Analysis

Customized services, reduced cost and access to advanced technologies offered by contract research service providers, have prompted a number of pharmaceutical companies to outsource their research operations London Roots Analysis has announced the addition of “Pharmaceutical Contract Research Services Market, 2021-2030” report to its list of offerings. Majority of the small companies as well as a few mid to large sized players, do not have the required capital or experience to undertake

Novel Drug Reconstitution Systems Market, 2021-2030

Roots Analysis has announced the addition of “Novel Drug Reconstitution Systems Market, 2021-2030” report to its list of offerings. To order this 320+ page report, which features 230 figures and 248 tables, please visit https://www.rootsanalysis.com/reports/drug-reconstitution-systems-market.html Key Inclusions  A detailed assessment of the current market landscape of novel drug reconstitution systems, providing information on the type of device (prefilled syringe, cartridge, infusion bags), type of chamber (dual chamber, multi chamber), physical

The “RAS Targeting Therapies Market, 2021-2031” report features an extensive …

To order this 140+ page report, which features 95+ figures, please visit https://www.rootsanalysis.com/reports/ras-targeting-therapies-market.html Key Inclusions  A detailed overview of the current market landscape of RAS targeting therapies, along with information on several relevant parameters, such as current status of development (marketed, clinical, pre-clinical and discovery), phase of development (phase III, phase II, phase I / II and phase I), type of molecule (biologic and small molecule), type of therapy (monotherapy and combination

The novel ocular drug delivery devices market is projected to grow at a CAGR of …

The delivery of drugs in ocular regions is known to be considerably more challenging; several pharmaceutical companies are actively undertaking initiatives to identify novel approaches for safe and efficient administration of therapies to eyes Roots Analysis has announced the addition of the “Novel Ocular Drug Delivery Devices Market, 2021 – 2030” report to its list of offerings. Over the years, a number of companies have developed several novel and advanced drug

The top selling biologics market is projected to be worth USD 156 billion by 203 …

Owing to the numerous benefits offered by biologics, this drug class has become an integral part of the overall pharmaceutical industry, having captured a significant market share over the past couple of decades Roots Analysis has announced the addition of the “Top Selling Biologics Market, 2021 – 2030” report to its list of offerings. Over the years, around 200 biologics have been approved for the treatment of various disease indications in

The bioprocess controllers and automation systems market is projected to be grow …

Owing to their advanced features and cost saving potential, bioprocess controllers and automation systems have been adopted widely by stakeholders in order to optimize and fasten the manufacturing process of biologics Roots Analysis has announced the addition of “Bioprocess Controllers and Automation Systems Market, 2021-2030” report to its list of offerings. The bioprocess controllers and automation systems have turned out to be a process optimization solution for the biopharmaceutical industries, overcoming

The TIL-based therapies market is projected to be worth over USD 4.3 billion, by …

The TIL-based therapies market is projected to be worth over USD 4.3 billion, by 2030, claims Roots Analysis LONDON, ENGLAND, UNITED KINGDOM, October 5, 2021 /EINPresswire.com/ -- Driven by the potential to confer sustained therapeutic effects and thereby, facilitate prolonged periods of remission, TIL-based therapies have received significant financial support, and promising leads are poised to soon achieve blockbuster status Roots Analysis has announced the addition of “TIL-based Therapies Market, 2021-2030” report

The on-body drug delivery-related intellectual landscape report identifies and a …

Several innovative drug delivery technologies have gathered notable momentum (in terms of adoption and sales) soon after entering the market; most of these are designed to address the unmet needs of administering complex pharmacological interventions Roots Analysis has announced the addition of the “On-body Drug Delivery Devices - Intellectual Property Landscape: Focus on Popular / Relevant Prior Art Search Expressions, Patent Valuation, Pockets of Innovation / White Spaces, and Key Applicant

The biospecimen contract research market is projected to grow at a noteworthy pa …

In the ongoing COVID-19 pandemic, a surge in the number of research studies has been observed, presenting lucrative opportunities for biospecimen service providers having the capabilities to offer high-quality biospecimens and associated analytical services London Roots Analysis has announced the addition of “Biospecimen Contract Research Services Market, 2021 – 2030” report to its list of offerings. Given the growing number of research and development initiatives in the pharmaceutical industry, and the rising number

With over 20 approved products and several more in the pipeline, the HUMIRA® bi …

Unlike other biosimilar markets, competition among follow-on products of HUMIRA® is very high and several eager companies are attempting to carve out a share of the multibillion-dollar opportunity associated with this blockbuster product Roots Analysis has announced the addition of the “HUMIRA® (Adalimumab) Biosimilars – Pipeline Review and Partnerships” report to its list of offerings. Being one of the first biologics against anti-inflammatory diseases, HUMIRA® is considered an aberration in terms of

The non-hormonal therapies market is projected to be worth USD 10.9 billion in 2 …

Driven by the potential to confer safe and sustained therapeutic effects for clinical conditions unique to women, the non-hormonal therapies pipeline is growing, featuring candidates having improved risk profiles and lesser side effects Roots Analysis has announced the addition of “Non-hormonal Therapies for Women’s Health Market 2021 – 2030” report to its list of offerings. In pursuit of an advantageous and risk-free prospect to hormonal therapies, the success of 21 approved

The glycosylation analysis services market is projected to reach nearly USD 2.5 …

The rapidly growing pipeline of recombinant glycoprotein therapeutics, especially the glycoengineered variants of COVID-19 drugs, has presented lucrative opportunities for contract service providers with expertise in glycoconjugate/glycan analysis London Roots Analysis has announced the addition of “Glycosylation Analysis Services Market, 2021 – 2030” report to its list of offerings. Profiling and in-depth characterization of glycosylated molecules in biotherapeutic and research samples require specialized equipment and focused expertise, which has prompted the research

The continuous and semi-continuous bioprocessing market is projected to grow at …

The surge in demand for COVID-19 vaccines has presented lucrative opportunities for both innovators and contract service providers having continuous and semi-continuous manufacturing capabilities for biointensification London Roots Analysis has announced the addition of “Continuous and Semi-Continuous Bioprocessing Market, 2021 – 2030” report to its list of offerings. Given the growing pipeline of biological drugs, and the rising preference for such therapeutic interventions, the demand for cost-effective biomanufacturing processes has increased. As a

The glycosylation analysis services market is projected to reach nearly USD 2.5 …

The rapidly growing pipeline of recombinant glycoprotein therapeutics, especially the glycoengineered variants of COVID-19 drugs, has presented lucrative opportunities for contract service providers with expertise in glycoconjugate / glycan analysis London Roots Analysis has announced the addition of “Glycosylation Analysis Services Market, 2021 – 2030” report to its list of offerings. Profiling and in-depth characterization of glycosylated molecules in biotherapeutic and research samples require specialized equipment and focused expertise, which has prompted

The CRISPR based therapeutics market is projected to be worth around USD 2.2 bil …

Considering its potential to intricately alter genetic DNA, the CRISPR technology is being widely used to develop viable therapeutics for the treatment of rare and complex genetic disorders, which are currently considered untreatable Roots Analysis has announced the addition of “CRISPR based Therapeutics Market, 2021-2030” report to its list of offerings. With over 115 candidates under development for various indications, the future of this niche market seems promising. The year 2020

The global cell therapy packaging services market is projected to be worth USD 1 …

With the growing pipeline of cell therapy products as potential treatments options for a myriad of diseases, drug developers are likely to collaborate with players offering packaging and logistics services to ensure safe and timely supply to the patients London Roots Analysis has announced the addition of “Cell Therapy Packaging Products and Services Market, 2021-2030”report to its list of offerings. Currently, more than 30 cell therapies have received marketing approvals across the world,

The TIL-based therapies market is projected to be worth over USD 4.3 billion, by …

Driven by the potential to confer sustained therapeutic effects and thereby, facilitate prolonged periods of remission, TIL-based therapies have received significant financial support, and promising leads are poised to soon achieve blockbuster status Roots Analysis has announced the addition of “TIL-based Therapies Market, 2021-2030” report to its list of offerings. Given the frequently reported inadequacies of conventional cancer therapies and the growing need for personalized medicine, there is a marked surge

Go To Page:   1 2 3 4 5 6 7 8 9 10